NeutralLOW severityHealthcare & Pharma45d ago

Century Therapeutics presents diabetes therapy data at EASD

Century Therapeutics presents diabetes therapy data at EASD — $IPSC one-month chart
$IPSC daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about IPSC. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · century therapeuticsEvent risk Low

Nothing reported about century therapeutics across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 97% a year
Now $1.64Week $1.42–$1.86 (±13.7%)Month $1.18–$2.10 (±28.1%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: Policy moves the whole healthcare aisle; trial data moves one company. Knowing which kind of story this is helps.
  • How the stock is trading: $IPSC -0.61% in the latest session.
  • Timing: It came out pre-market, so the next session was the first that could react.

Where the stock stands

Century Therapeutics ($IPSC) slipped 0.61% to $1.64 in the latest session. Over the past month it is up 11.6%. That leaves it 46% below its 52-week high of $3.04 and 277% above its low of $0.44. It has been a volatile year: the high was 7.0 times the low, so moves this size are not unusual for it.

What the filings say

In its latest report (10-Q, filed Nov 12, 2026), $IPSC lost $23.5M over the quarter to Sep 30, 2026. Operations used $67.3M of cash over the nine months to Sep 30, 2026 — about $7.5M a month — against $45.0M in cash on Sep 30, 2026. At that pace the cash covers about 6 months, which is why financing, asset sales or restructuring tend to come up for companies in this position. Total liabilities were $52.7M against $45.0M of cash on Sep 30, 2026. The company filed an 8-K — the form for material events — on Oct 2, the same day as this story; it is $IPSC's own account and the first thing to read. Figures are as filed with the SEC; the $IPSC page has the full statements.

How much coverage it is getting

This story is more than a month old. Since then Wook has filed one newer story on Century Therapeutics, published this week. It reads bullish.

The bigger picture

Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner shows no unusual stress in Health Care today.

What to watch next

For the company's side of it, read its latest SEC filings on the $IPSC page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Where several outlets agree is usually the news; where they differ is the angle. To run the numbers yourself, ask Wook AI above about $IPSC: its distance from the high, its last report, or how coverage has changed.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Investing.com published this on October 2, 2026. $IPSC has moved +7.19% ($1.53 to $1.64). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Investing.com. Wook of Wall Street is an independent research tool and is not affiliated with Investing.com. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy